APC Annexin V Apoptosis Detection Kit with PI

Pricing & Availability
Regulatory Status
Other Names
Annexin A5 Apoptosis Detection Kit
Ave. Rating
Submit a Review
Product Citations
Human T leukemia cell line Jurkat, treated (left) or non-treated (right) with BioLegend’s anti-human CD95 (EOS9.1) mAb (Cat. No. 305704) for 4 hours at 37°C, then stained with Annexin V- APC for 15 minutes at 37°C in Annexin V Binding buffer. Propidium Iodide (PI) (0.03 µg/Test Cat. No. 421301) was added 5 minutes prior to running tubes.
  • APC_Annexin-V_kit_052318
    Human T leukemia cell line Jurkat, treated (left) or non-treated (right) with BioLegend’s anti-human CD95 (EOS9.1) mAb (Cat. No. 305704) for 4 hours at 37°C, then stained with Annexin V- APC for 15 minutes at 37°C in Annexin V Binding buffer. Propidium Iodide (PI) (0.03 µg/Test Cat. No. 421301) was added 5 minutes prior to running tubes.
See APC spectral data
Cat # Size Price Quantity Check Availability Save
640932 100 tests £183
Check Availability

Need larger quantities of this item?
Request Bulk Quote

BioLegend's APC Annexin V Apoptosis Detection Kit with PI has been specifically designed for the identification of apoptotic and necrotic cells.

Annexin V (or Annexin A5) is a member of the annexin family of intracellular proteins that binds to phosphatidylserine (PS) in a calcium-dependent manner. PS is normally only found on the intracellular leaflet of the plasma membrane in healthy cells, but during early apoptosis, membrane asymmetry is lost and PS translocates to the external leaflet. Fluorochrome-labeled Annexin V can then be used to specifically target and identify apoptotic cells. Annexin V Binding Buffer is recommended for use with Annexin V staining. Annexin V binding alone cannot differentiate between apoptotic and necrotic cells. To help distinguish between the necrotic and apoptotic cells we recommend use of our Propidium Iodide Solution (PI). Early apoptotic cells will exclude PI, while late stage apoptotic cells and necrotic cells will stain positively, due to the passage of these dyes into the nucleus where they bind to DNA.

Propidium iodide is a fluorescent dye that binds to DNA. When excited by 488 nm laser light, it can be detected with in the PE/Texas Red® channel with a bandpass filter 610/10. It is commonly used in evaluation of cell viability or DNA content in cell cycle analysis by flow cytometry.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
All mammalian species
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
Store between 2°C and 8°C. Do not freeze.

Caution: Propidium Iodide Solution is toxigenic and mutagenic; handle with care.

FC - Quality tested

Recommended Usage

Staining Procedure:
1. Wash cells twice with cold BioLegend's Cell Staining Buffer, and then resuspend cells in Annexin V Binding Buffer at a concentration of 0.25-1.0 x 107 cells/mL.
2. Transfer 100 µL of cell suspension in a 5 mL test tube.
3. Add 5 µL of APC Annexin V.
4. Add 10 µL of Propidium Iodide Solution.
5. Gently vortex the cells and incubate for 15 min at room temperature (25°C) in the dark.
6. Add 400 µL of Annexin V Binding Buffer to each tube. Analyze by flow cytometry with proper machine settings.

Application Notes

Materials Provided:
0.5 ml of APC Annexin V
1 ml of Propidium Iodide Solution
50 ml of Annexin V Binding Buffer

Materials Not Included:
Cell Staining Buffer (Cat. No. 420201)

For a better experience detecting apoptosis, we now recommend Apotracker™. Cell staining with Apotracker™ is Calcium independent. Thus, no special buffers are required, and the protocol can be shortened for single-step co-staining with other reagents.

Application References

(PubMed link indicates BioLegend citation)
  1. Ranganathan P, et al. 2014. J AM Soc Nephrol. 25:239. PubMed
  2. Bernhart E, et al. 2014. Neuro Onco. 16:933. PubMed
Product Citations
  1. Zhou L, et al. 2020. Oxid Med Cell Longev. 2685310:2020. PubMed
  2. Shrestha C,et al. 2017. PLoS One. 10.1371/journal.pone.0186169. PubMed
  3. Bikorimana JP, et al. 2022. iScience. 25:105537. PubMed
  4. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  5. Chaturvedi S, et al. 2022. Cell. 185:2086. PubMed
  6. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  7. Wang H, et al. 2020. Onco Targets Ther. 13:3903. PubMed
  8. O'Connor CM, et al. 2022. Cancer Res. 82:721. PubMed
  9. Blackburn CMR, et al. 2021. Atherosclerosis. 330:76. PubMed
  10. Azad P, et al. 2022. Exp Mol Med. :. PubMed
  11. Vitali E, et al. 2020. Cancers (Basel). 12:00. PubMed
  12. Daza–Cajigal V, et al. 2019. Front Immunol. 10:2065. PubMed
  13. Cremasco F, et al. 2021. PLoS One. 16:e0241091. PubMed
  14. Wang F, et al. 2021. J Exp Clin Cancer Res. 40:259. PubMed
  15. Sun X, et al. 2022. JCI Insight. 7: . PubMed
  16. Lv ZY, et al. 2022. J Inflamm Res. 15:2819. PubMed
  17. Dichtl S, et al. 2021. Sci Adv. 7: . PubMed
  18. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  19. Liu K, et al. 2021. Front Cell Dev Biol. 9:678209. PubMed
  20. Zou J, et al. 2015. PLoS One. 10: 0136843. PubMed
  21. Portman N, et al. 2020. Breast Cancer Res. 0.977083333. PubMed
  22. Wang Z, et al. 2017. Elife. 6:e30590. PubMed
  23. Wang J, et al. 2021. Int J Mol Med. 47:643. PubMed
  24. Yetkin D, et al. 2021. EXCLI J. 20:1394. PubMed
  25. Takahashi H, et al. 2019. Sci Rep. 1.136111111. PubMed
  26. Daza-Cajigal V, et al. 2022. Front Immunol. 13:888427. PubMed
  27. Li T, et al. 2021. Front Cell Dev Biol. 9:599020. PubMed
  28. Qi T, et al. 2022. Invest Ophthalmol Vis Sci. 63:11. PubMed
  29. Zhang Y, et al. 2021. Cell Death Discov. 7:192. PubMed
  30. Gomzikova MO, et al. 2020. Sci Rep. 10:10740. PubMed
  31. Nassa G, et al. 2019. Sci Adv. 5:eaav5590. PubMed
  32. Karagül MI, et al. 2020. EXCLI J. 19:532. PubMed
  33. Liu C, et al. 2021. Immun Inflamm Dis. 9:1749. PubMed
  34. Bernhart E, et al. 2014. Neuro Oncology. 16:933. PubMed
  35. Deventhiran J, et al. 2016. J Virol. 90: 222 - 231. PubMed
  36. He L, et al. 2021. Front Physiol. 12:664222. PubMed
  37. Yan Y, et al. 2021. Br J Cancer. 125:101. PubMed
  38. Zhang N, et al. 2021. Atherosclerosis. 334:39. PubMed
  39. Quintanal-Villalonga A, et al. 2022. Cancer Res. 82:472. PubMed
  40. Li Y, et al. 2020. Nat Cancer. 1:882. PubMed
  41. Gong Y, et al. 2020. J Neuroinflammation. 0.845833333. PubMed
  42. Zhang S, et al. 2021. Cell Death Discov. 49:7. PubMed
  43. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  44. Lyu X, et al. 2022. Discov Oncol. 13:30. PubMed
  45. Harro CM, et al. 2020. J Clin Invest. . PubMed
  46. Gantenbein N, et al. 2018. Eur J Cancer. 101:165. PubMed
  47. González-Rodríguez P, et al. 2022. Cell Death Dis. 13:953. PubMed
  48. Lohberger B, et al. 2016. PLoS One. 11:e0168193. PubMed
  49. Przystupski D, et al. 2019. Front Pharmacol. 10:851. PubMed
  50. Dudek M, et al. 2021. Nature. 592:444. PubMed
  51. Javellana M, et al. 2022. Cancer Res. 82:169. PubMed
  52. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  53. Surya R, et al. 2016. Carcinogenesis. 37: 635 - 645. PubMed
  54. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  55. Pogozhykh D, et al. 2017. Stem Cell Res Ther. 10.1186/s13287-017-0512-7. PubMed
  56. Widodo N, et al. 2022. F1000Res. 11:169. PubMed
  57. He S, et al. 2022. Ren Fail. 44:171. PubMed
  58. Baxley RM, et al. 2021. Nat Commun. 1626:12. PubMed
  59. Schnoor B, et al. 2022. Front Bioeng Biotechnol. 10:941817. PubMed
  60. Morretton JP, et al. 2022. EMBO Mol Med. 14:e15670. PubMed

Antigen Details

Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Cell Proliferation and Viability, Neuroscience
Gene ID
308 View all products for this Gene ID

Related FAQs

How is your Annexin made and what sequence does it cover?

It is made in E. coli, covering human aa Met1-Asp320.

How does pH and staining temperature affect Annexin V-Phosphatidylserine binding?

Annexin-Phosphatidylserine binding is lost below pH 5.2 and with prolonged incubation over a temperature of 42°C.

Why do I need to use Annexin V Binding Buffer?

Annexin V binding requires the presence of calcium in the solution.  So, we provide Annexin V Binding Buffer (cat # 422201), which is optimized for the best performance of Annexin V staining.

Can I use RPMI during Annexin V staining?

It is best to follow protocol as described on the product data sheet. Moreover, RPMI 1640 has a relatively high concentration of phosphate and low calcium ion concentration, which negatively impacts Annexin binding to its target phosphatidylserine (PS). Measurement of cell death by using Annexin V may also be significantly affected by time of incubation on ice, calcium concentration, and type of medium.

Can I freeze Annexin V conjugates?

It should not be frozen as it will lead to loss of biological activity due to dimerization.

Is Annexin V suitable for conjugation with the Maxpar® kit for CyTOF®?

Maxpar® Labeling kits require the protein to be partially reduced, so the metal chelate can be introduced through an SH group in the hinge region of the reduced antibody. Human Annexin V contains only one Cysteine which was reported to be chemically inactive. Thus, the Maxpar® labeling protocol would not work with Annexin V, unless a free –SH group can be introduced to Annexin V.  For more information regarding SH-mediated conjugation of Annexin V please consult published papers such as this one.

Go To Top Version: 2    Revision Date: 05/23/2018

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.


*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.


8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.


Login / Register
Remember me
Forgot your password? Reset password?
Create an Account